Hi-Tech Pharmacal Co. Inc. - PharmaTrack

  • ID: 228323
  • September 2004
  • 26 pages
  • Scope eKnowledge Center Pvt Ltd
1 of 3

PharmaTrack is a compendium of 500 profiles of healthcare & life sciences companies. The coverage is dominated by mid-cap companies, particularly those that don’t have adequate analyst coverage, making it a high-in-demand, value added research product. This report profiles Hi-Tech Pharmacal Co. Inc. <BR><BR>Each PharmaTrack Profile is packed with crucial data & information and in-depth analysis. The profile elaborates on the company’s business structure and operations, products and services. It extensively discusses the company’s financial performance and strategic imperatives from an investor’s perspective and provides a reliable outlook for the future.<BR><BR>Scope of the Report<BR><BR>- Provides key company data and analysis to industry players, which is vital to enhance business and competitor intelligence and facilitate decision making<BR><BR>- Analyzes the industry and the segment to which the company belongs in a concise manner.<BR><BR>- Compares the company vis-à-vis its peers in a detailed manner<BR><BR>- Discusses also the current industry status and the significant READ MORE >

Note: Product cover images may vary from those shown
2 of 3

Company Brief 1 <BR><BR>Key Highlights 1 <BR>- Stock Data – Last 3 years to date 2 <BR>- Stock Data – Last 52 weeks 2 <BR><BR>Industry Overview 3 <BR><BR>Company Overview 10 <BR><BR>Management Structure 11 <BR><BR>Shareholding Pattern 11 <BR>- Insider Ownership 11 <BR>- Institutional Ownership 12 <BR>- Public 12 <BR><BR>Major Operations 12 <BR>- Manufacturing Facilities 12 <BR>- Products and Customers 12 <BR>- Marketing Efforts 13 <BR>- Ongoing Developments & Programs 13 <BR><BR>Key Partnerships 13 <BR><BR>Market Position – Comparison with Industry Peers 14 <BR><BR>Strategic Overview 15 <BR>- SWOT Analysis 15 <BR><BR>Strategic Focus 20 <BR>- Focus on New Product Launches 20 <BR>- Enhancing Prospects in the Diabetes Market 21 <BR><BR>Financial Performance 22 <BR>- Quarterly Performance- Final Quarter of Fiscal 2004 22 <BR>- Full –Year Performance 23 <BR><BR>Risk Factors 25 <BR><BR>Outlook 26

Note: Product cover images may vary from those shown
3 of 3
Note: Product cover images may vary from those shown


  • Quick Help: The report will be emailed to you.


If you have a more general question about our products please try our



Our Clients

  • Fluidigm Corporation
  • Apple, Inc.
  • CEVA Santé Animale
  • Abbott Laboratories Ltd.
  • Merck Group
  • Allergan Inc.
  • Pfizer, Inc.